Pancreatic Cancer Treatment Market By Type and Affected Region- Global Industry Analysis and Forecast to 2023

Published On : December 2017 Pages : 90 Category: Medical Devices Report Code : HC12412

Industry Outlook and Trend Analysis

The Pancreatic Cancer Treatment Market was worth USD 1.65 billion in the year of 2014 and is expected to reach approximately USD 4.11 billion by 2023, while registering itself at a compound annual growth rate (CAGR) of 10.64% during the forecast period. The rising pervasiveness of smoking, obesity, and alcohol consumption is foreseen to boost the market development. Moreover, developing aged populace is normal drive the development of the pancreatic tumor treatment industry amid the figure time frame. Aside from factors that are associated with lifestyle, a personal or family history of pancreatitis and BRCA2 mutation inclines a man to pancreatic cancer. A number of imaging systems, for example, MRI, CT scan, and ultrasound are utilized for determination of the illness. Chemotherapy is the most widely recognized type of treatment gave by medical specialists and oncologists. In emerging nations, governments are consistently contributing enormous measure of assets to enhance patient-centered care. Expanding aged populace base, rising commonness of pancreatic tumor cases, and quick development in remote ventures are foreseen to be seen over the figure time frame in the creating countries of Asia Pacific and Middle East area.

Pancreatic Cancer Treatment Market

Affected Region Outlook and Trend Analysis

The worldwide pancreatic cancer treatment sector has been sectioned into kind of influenced locale and application. The influenced district portion is classified into endocrine and exocrine. The majority of the pancreatic growths analyzed on the planet have a place with exocrine class, in this way the fragment at present commands the market. The endocrine type of cancers, although less common, is as yet anticipating successful treatment modalities. The investment on research and development is significant in the two types of cancer. However, the expanding predominance and developing compass of novel strategies in the developing areas are the elements anticipated that would drive the development of the exocrine section all through the conjecture time frame.

Type Outlook and Trend Analysis

In terms of type, the pancreatic cancer market is divided into targeted therapy, chemotherapy, and others that principally incorporate radiation techniques, surgery, and different treatments. Directed treatment overwhelmed the market in 2015 and is foreseen to command all through the figure time frame. The variables driving development incorporate presentation of the novel biologic treatments and focused on drugs so as to limit the unfriendly impacts of the current treatments, including chemotherapy. Interest for focused medications is foreseen to rise fundamentally amid the estimate time frame.

Regional Outlook and Trend Analysis

North America ruled the pancreatic cancer treatment industry with biggest income share in 2015. The strength of this area is for the most part ascribed to the enhanced healthcare foundation, high implementation of pancreatic treatment strategies, and the existence of vast target populace. Furthermore, expanding frequency of pancreatic disease is forcefully pushing the interest for treatment choices. Furthermore, Asia Pacific is foreseen to encounter the quickest development amid the estimate time frame. Existence of settled healing facilities and basic care focuses and additionally substantial populace experiencing pancreatic cancer would support the development of the market in Asia Pacific area.

Competitive Insights

The market is consolidated with some major players such as Roche Holding AG, Eli Lilly and Company, Celgene Corporation, Novartis AG, Pfizer, Clovis Oncology, Amgen, Teva Pharmaceutical Industries Ltd and Merck & Co. Various organizations are concentrating on the presentation of mechanically propelled products with a specific end goal to pick up a solid footing in the quickly growing medicinal device part. Likewise, collaborations, partnerships, and mergers with settled players are the significant procedures adopted by top players to build the share of the market amid the figure time frame.

The Pancreatic Cancer Treatment market is segmented as follows-

By Affected Region:

  • Endocrine
  • Exocrine

By Type:

  • Targeted Therapy
  • Chemotherapy
  • Others

By Region

  • North America
  • U.S
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • Australia
  • India
  • South Korea
  • Rest of Asia Pacific
  • Rest of the World
  • Brazil
  • South Africa
  • Saudi Arabia
  • United Arab Emirates
  • Others

Some of the key questions answered by the report are:

  • What was the market size in 2014 and forecast from 2015 to 2023?
  • What will be the industry market growth from 2015 to 2023?
  • What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
  • What are the major segments leading the market growth and why?
  • Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

 

Market Classification

  • Pancreatic Cancer Treatment Market, By Type, Estimates and Forecast, 2014-2023($Million)
    • Targeted Therapy
    • Chemotherapy
    • Other Types
  • Pancreatic Cancer Treatment Market, By Affected Region, Estimates and Forecast, 2014-2023($Million)
    • Endocrine
    • Exocrine
  • Pancreatic Cancer Treatment Market, By Region, Estimates and Forecast, 2014-2023($Million)
    • North America
  • North America  Pancreatic Cancer Treatment Market, By Country
  • North America  Pancreatic Cancer Treatment Market, By Type
  • North America  Pancreatic Cancer Treatment Market, By Affected Region
    • U.S.  Pancreatic Cancer Treatment Market, By Type
    • U.S. Pancreatic Cancer Treatment Market, By Affected Region
    • Canada  Pancreatic Cancer Treatment Market, By Type
    • Canada  Pancreatic Cancer Treatment Market, By Affected Region
    • Mexico  Pancreatic Cancer Treatment Market, By Type
    • Mexico  Pancreatic Cancer Treatment Market, By Affected Region
    • Europe
  • Europe Pancreatic Cancer Treatment Market, By Country
  • Europe Pancreatic Cancer Treatment Market, By Type
  • Europe Pancreatic Cancer Treatment Market, By Affected Region
    • Germany  Pancreatic Cancer Treatment Market, By Type
    • Germany  Pancreatic Cancer Treatment Market, By Affected Region
    • France Pancreatic Cancer Treatment Market, By Type
    • France Pancreatic Cancer Treatment Market, By Affected Region
    • UK   Pancreatic Cancer Treatment Market, By Type
    • UK   Pancreatic Cancer Treatment Market, By Affected Region
    • Italy   Pancreatic Cancer Treatment Market, By Type
    • Italy   Pancreatic Cancer Treatment Market, By Affected Region
    • Spain   Pancreatic Cancer Treatment Market, By Type
    • Spain   Pancreatic Cancer Treatment Market, By Affected Region
    • Rest of Europe   Pancreatic Cancer Treatment Market, By Type
    • Rest of Europe   Pancreatic Cancer Treatment Market, By Affected Region
    • Asia-Pacific
      • Asia-Pacific   Pancreatic Cancer Treatment Market, By Country
      • Asia-Pacific   Pancreatic Cancer Treatment Market, By Type
      • Asia-Pacific   Pancreatic Cancer Treatment Market, By Affected Region
        • Japan   Pancreatic Cancer Treatment Market, By Type
        • Japan   Pancreatic Cancer Treatment Market, By Affected Region
        • Australia   Pancreatic Cancer Treatment Market, By Type
        • Australia   Pancreatic Cancer Treatment Market, By Affected Region
        • India   Pancreatic Cancer Treatment Market, By Type
        • India   Pancreatic Cancer Treatment Market, By Affected Region
        • South Korea   Pancreatic Cancer Treatment Market, By Type
        • South Korea   Pancreatic Cancer Treatment Market, By Affected Region
        • Rest of Asia-Pacific   Pancreatic Cancer Treatment Market, By Type
        • Rest of Asia-Pacific   Pancreatic Cancer Treatment Market, By Affected Region
    • Rest of the World
      • Rest of the World   Pancreatic Cancer Treatment Market, By Country
      • Rest of the World   Pancreatic Cancer Treatment Market, By Type
      • Rest of the World   Pancreatic Cancer Treatment Market, By Affected Region
        • Brazil   Pancreatic Cancer Treatment Market, By Type
        • Brazil   Pancreatic Cancer Treatment Market, By Affected Region
        • South Africa   Pancreatic Cancer Treatment Market, By Type
        • South Africa   Pancreatic Cancer Treatment Market, By Affected Region
        • Saudi Arabia   Pancreatic Cancer Treatment Market, By Type
        • Saudi Arabia   Pancreatic Cancer Treatment Market, By Affected Region
        • Turkey   Pancreatic Cancer Treatment Market, By Type
        • Turkey   Pancreatic Cancer Treatment Market, By Affected Region
        • United Arab Emirates   Pancreatic Cancer Treatment Market, By Type
        • United Arab Emirates   Pancreatic Cancer Treatment Market, By Affected Region
        • Others   Pancreatic Cancer Treatment Market, By Type
        • Others   Pancreatic Cancer Treatment Market, By Affected Region

Table of Contents

1.       Introduction

1.1.       Report Description

1.2.       Research Methodology

2.       Executive Summary

2.1.       Key Highlights

3.       Market Overview

3.1.       Introduction

3.1.1.  Market Definition

3.1.2.  Market Segmentation

3.2.       Market Dynamics

3.2.1.  Drivers

3.2.1.1.    Rising Geriatric Population

3.2.1.2.    Changing Lifestyles

3.2.2.  Restraints

3.2.2.1.    Presence of Low Cost Substitutes

3.2.3.  Opportunities

3.2.3.1.    Emerging Markets to Offer Lucrative Growth Opportunities

4.       Pancreatic Cancer Treatment Market, By Type

4.1.       Introduction

4.2.       Pancreatic Cancer Treatment Market  Assessment and Forecast, By Type, 2014-2023

4.3.       Targeted Therapy

4.3.1.  Market Assessment and Forecast, By Region, 2014-2023 ($Million)

4.4.       Chemotherapy

4.4.1.  Market Assessment and Forecast, By Region, 2014-2023 ($Million)

4.5.       Other Types

4.5.1.  Market Assessment and Forecast, By Region, 2014-2023 ($Million)

5.       Pancreatic Cancer Treatment Market, By Affected Region

5.1.       Introduction

5.2.       The Pancreatic Cancer Treatment Market   Assessment and Forecast, By Affected Region, 2014-2023

5.3.       Endocrine

5.3.1.  Market Assessment and Forecast, By Region, 2014-2023 ($Million)

5.4.       Exocrine

5.4.1.  Market Assessment and Forecast, By Region, 2014-2023 ($Million)

6.       Pancreatic Cancer Treatment Market,By Region

6.1.       Introduction

6.2.       Pancreatic Cancer Treatment Market   Assessment and Forecast, By Type, 2014-2023 ($Million)

6.3.       Pancreatic Cancer Treatment Market   Assessment and Forecast, By Affected Region , 2014-2023 ($Million)

6.4.       North America

6.4.1.  Market Assessment and Forecast, By Country, 2014-2023 ($Million)

6.4.2.  Market Assessment and Forecast, By Type, 2014-2023 ($Million)

6.4.3.  Market Assessment and Forecast, By Affected Region, 2014-2023 ($Million)

6.4.4.  U.S.

6.4.4.1.    Market Assessment and Forecast, By Type, 2014-2023 ($Million)

6.4.4.2.    Market Assessment and Forecast, By Affected Region, 2014-2023 ($Million)

6.4.5.  Canada

6.4.5.1.    Market Assessment and Forecast, By Type, 2014-2023 ($Million)

6.4.5.2.    Market Assessment and Forecast, By Affected Region, 2014-2023 ($Million)

6.4.6.  Mexico

6.4.6.1.    Market Assessment and Forecast, By Type, 2014-2023 ($Million)

6.4.6.2.    Market Assessment and Forecast, By Affected Region, 2014-2023 ($Million)

6.5.       Europe

6.5.1.  Market Assessment and Forecast, By Country, 2014-2023 ($Million)

6.5.2.  Market Assessment and Forecast, By Type, 2014-2023 ($Million)

6.5.3.  Market Assessment and Forecast, By Affected Region, 2014-2023 ($Million)

6.5.4.  Germany

6.5.4.1.    Market Assessment and Forecast, By Type, 2014-2023 ($Million)

6.5.4.2.    Market Assessment and Forecast, By Affected Region, 2014-2023 ($Million)

6.5.5.  France

6.5.5.1.    Market Assessment and Forecast, By Type, 2014-2023 ($Million)

6.5.5.2.    Market Assessment and Forecast, By Affected Region, 2014-2023 ($Million)

6.5.6.  UK

6.5.6.1.    Market Assessment and Forecast, By Type, 2014-2023 ($Million)

6.5.6.2.    Market Assessment and Forecast, By Affected Region, 2014-2023 ($Million)

6.5.7.  Italy

6.5.7.1.    Market Assessment and Forecast, By Type, 2014-2023 ($Million)

6.5.7.2.    Market Assessment and Forecast, By Affected Region, 2014-2023 ($Million)

6.5.8.  Spain

6.5.8.1.    Market Assessment and Forecast, By Type, 2014-2023 ($Million)

6.5.8.2.    Market Assessment and Forecast, By Affected Region, 2014-2023 ($Million)

6.5.9.  Rest of Europe

6.5.9.1.    Market Assessment and Forecast, By Type, 2014-2023 ($Million)

6.5.9.2.    Market Assessment and Forecast, By Affected Region, 2014-2023 ($Million)

6.6.       Asia-Pacific

6.6.1.  Market Assessment and Forecast, By Country, 2014-2023 ($Million)

6.6.2.  Market Assessment and Forecast, By Type, 2014-2023 ($Million)

6.6.3.  Market Assessment and Forecast, By Affected Region, 2014-2023 ($Million)

6.6.4.  Japan

6.6.4.1.    Market Assessment and Forecast, By Type, 2014-2023 ($Million)

6.6.4.2.    Market Assessment and Forecast, By Affected Region, 2014-2023 ($Million)

6.6.5.  China

6.6.5.1.    Market Assessment and Forecast, By Type, 2014-2023 ($Million)

6.6.5.2.    Market Assessment and Forecast, By Affected Region, 2014-2023 ($Million)

6.6.6.  Australia

6.6.6.1.    Market Assessment and Forecast, By Type, 2014-2023 ($Million)

6.6.6.2.    Market Assessment and Forecast, By Affected Region, 2014-2023 ($Million)

6.6.7.  India

6.6.7.1.    Market Assessment and Forecast, By Type, 2014-2023 ($Million)

6.6.7.2.    Market Assessment and Forecast, By Affected Region, 2014-2023 ($Million)

6.6.8.  South Korea

6.6.8.1.    Market Assessment and Forecast, By Type, 2014-2023 ($Million)

6.6.8.2.    Market Assessment and Forecast, By Affected Region, 2014-2023 ($Million)

6.6.9.  Rest of Asia-Pacific

6.6.9.1.    Market Assessment and Forecast, By Type, 2014-2023 ($Million)

6.6.9.2.    Market Assessment and Forecast, By Affected Region, 2014-2023 ($Million)

6.7.       Rest of the World

6.7.1.  Market Assessment and Forecast, By Country, 2014-2023 ($Million)

6.7.2.  Market Assessment and Forecast, By Type, 2014-2023 ($Million)

6.7.3.  Market Assessment and Forecast, By Affected Region, 2014-2023 ($Million)

6.7.4.  Brazil

6.7.4.1.    Market Assessment and Forecast, By Type, 2014-2023 ($Million)

6.7.4.2.    Market Assessment and Forecast, By Affected Region, 2014-2023 ($Million)

6.7.5.  Turkey

6.7.5.1.    Market Assessment and Forecast, By Type, 2014-2023 ($Million)

6.7.5.2.    Market Assessment and Forecast, By Affected Region, 2014-2023 ($Million)

6.7.6.  Saudi Arabia

6.7.6.1.    Market Assessment and Forecast, By Type, 2014-2023 ($Million)

6.7.6.2.    Market Assessment and Forecast, By Affected Region, 2014-2023 ($Million)

6.7.7.  South Africa

6.7.7.1.    Market Assessment and Forecast, By Type, 2014-2023 ($Million)

6.7.7.2.    Market Assessment and Forecast, By Affected Region, 2014-2023 ($Million)

6.7.8.  United Arab Emirates

6.7.8.1.    Market Assessment and Forecast, By Type, 2014-2023 ($Million)

6.7.8.2.    Market Assessment and Forecast, By Affected Region, 2014-2023 ($Million)

6.7.9.  Others

6.7.9.1.    Market Assessment and Forecast, By Type, 2014-2023 ($Million)

6.7.9.2.    Market Assessment and Forecast, By Affected Region, 2014-2023 ($Million)

7.       Company Profiles

7.1.       Roche Holding AG

7.1.1.  Business Overview

7.1.2.  Product Portfolio

7.1.3.  Key Financials

7.1.4.  Strategic Developments

7.2.       Eli Lilly and Company

7.2.1.  Business Overview

7.2.2.  Product Portfolio

7.2.3.  Key Financials

7.2.4.  Strategic Developments

7.3.       Celgene Corporation

7.3.1.  Business Overview

7.3.2.  Product Portfolio

7.3.3.  Key Financials

7.3.4.  Strategic Developments

7.4.       Novartis AG

7.4.1.  Business Overview

7.4.2.  Type  Portfolio

7.4.3.  Key Financials

7.4.4.  Strategic Developments

7.5.       Pfizer

7.5.1.  Business Overview

7.5.2.  Product Portfolio

7.5.3.  Strategic Developments

7.6.       Clovis Oncology

7.6.1.  Business Overview

7.6.2.  Product Portfolio

7.6.3.  Strategic Developments

7.7.       Amgen

7.7.1.  Business Overview

7.7.2.  Product  Portfolio

7.7.3.  Strategic Developments

7.8.       Teva Pharmaceutical Industries Ltd

7.8.1.  Business Overview

7.8.2.  Product  Portfolio

7.8.3.  Strategic Developments

7.9.       Merck & Co.

7.9.1.  Business Overview

7.9.2.  Product  Portfolio

7.9.3.  Key Financials

7.9.4.  Strategic Developments


List of Tables

Table 1.Global Pancreatic Cancer Treatment Market, By Type, 2014-2023 ($Million)
Table 2.Targeted Therapy Market, By Region, 2014-2023 ($Million)
Table 3.Chemotherapy Market, By Region, 2014-2023 ($Million)
Table 4.Other Types Market, By Region, 2014-2023 ($Million)
Table 5.Global Pancreatic Cancer Treatment Market, By Affected Region, 2014-2023 ($Million)
Table 6.Endocrine Market, By Region, 2014-2023 ($Million)
Table 7.Exocrine Market, By Affected Region, 2014-2023 ($Million)
Table 13.North America Pancreatic Cancer Treatment Market, By Country, 2014-2023 ($Million)
Table 14.North America Pancreatic Cancer Treatment Market, By Type, 2014-2023 ($Million)
Table 15.North America Pancreatic Cancer Treatment Market, By Affected Region, 2014-2023 ($Million)
Table 16.U.S. Pancreatic Cancer Treatment Market, By Type, 2014-2023 ($Million)
Table 17.U.S. Pancreatic Cancer Treatment Market, By Affected Region, 2014-2023 ($Million)
Table 18.Canada Pancreatic Cancer Treatment Market, By Type, 2014-2023 ($Million)
Table 19.Canada Pancreatic Cancer Treatment Market, By Affected Region, 2014-2023 ($Million)
Table 20.Mexico Pancreatic Cancer Treatment Market, By Type, 2014-2023 ($Million)
Table 21.Mexico Pancreatic Cancer Treatment Market, By Affected Region, 2014-2023 ($Million)
Table 22.Europe Pancreatic Cancer Treatment Market, By Country, 2014-2023 ($Million)
Table 23.Europe Pancreatic Cancer Treatment Market, By Type, 2014-2023 ($Million)
Table 24.Europe Pancreatic Cancer Treatment Market, By Affected Region, 2014-2023 ($Million)
Table 25.Germany Pancreatic Cancer Treatment Market, By Type, 2014-2023 ($Million)
Table 26.Germany Pancreatic Cancer Treatment Market, By Affected Region, 2014-2023 ($Million)
Table 27.France Pancreatic Cancer Treatment Market, By Type, 2014-2023 ($Million)
Table 28.France Pancreatic Cancer Treatment Market, By Affected Region, 2014-2023 ($Million)
Table 29.UK Pancreatic Cancer Treatment Market, By Type, 2014-2023 ($Million)
Table 30.UK Pancreatic Cancer Treatment Market, By Affected Region, 2014-2023 ($Million)
Table 31.Italy Pancreatic Cancer Treatment Market, By Type, 2014-2023 ($Million)
Table 32.Italy Pancreatic Cancer Treatment Market, By Affected Region, 2014-2023 ($Million)
Table 33.Spain Pancreatic Cancer Treatment Market, By Type, 2014-2023 ($Million)
Table 34.Spain Pancreatic Cancer Treatment Market, By Affected Region, 2014-2023 ($Million)
Table 35.Rest of Europe Pancreatic Cancer Treatment Market, By Type, 2014-2023 ($Million)
Table 36.Rest of Europe Pancreatic Cancer Treatment Market, By Affected Region, 2014-2023 ($Million)
Table 37.Asia-Pacific Pancreatic Cancer Treatment Market, By Country, 2014-2023 ($Million)
Table 38.Asia-Pacific Pancreatic Cancer Treatment Market, By Type, 2014-2023 ($Million)
Table 39.Asia-Pacific Pancreatic Cancer Treatment Market, By Affected Region, 2014-2023 ($Million)
Table 40.Japan Pancreatic Cancer Treatment Market, By Type, 2014-2023 ($Million)
Table 41.Japan Pancreatic Cancer Treatment Market, By Affected Region, 2014-2023 ($Million)
Table 42.China Pancreatic Cancer Treatment Market, By Type, 2014-2023 ($Million)
Table 43.China Pancreatic Cancer Treatment Market, By Affected Region, 2014-2023 ($ Million)
Table 44.Australia Pancreatic Cancer Treatment Market, By Type, 2014-2023 ($Million)
Table 45.Australia Pancreatic Cancer Treatment Market, By Affected Region, 2014-2023 ($ Million)
Table 46.India Pancreatic Cancer Treatment Market, By Type, 2014-2023 ($Million)
Table 47.India Pancreatic Cancer Treatment Market, By Affected Region, 2014-2023 ($ Million)
Table 48.South Korea Pancreatic Cancer Treatment Market, By Type, 2014-2023 ($Million)
Table 49.South Korea Pancreatic Cancer Treatment Market, By Affected Region, 2014-2023 ($ Million)
Table 50.Rest of Asia-Pacific Pancreatic Cancer Treatment Market, By Type, 2014-2023 ($Million)
Table 51.Rest of Asia-Pacific Pancreatic Cancer Treatment Market, By Affected Region, 2014-2023 ($ Million)
Table 52.Rest of the World Pancreatic Cancer Treatment Market, By Country, 2014-2023 ($Million)
Table 53.Rest of the World Pancreatic Cancer Treatment Market, By Type, 2014-2023 ($Million)
Table 54.Rest of the World Pancreatic Cancer Treatment Market, By Affected Region, 2014-2023 ($ Million)
Table 55.Brazil Pancreatic Cancer Treatment Market, By Type, 2014-2023 ($Million)
Table 56.Brazil Pancreatic Cancer Treatment Market, By Affected Region, 2014-2023 ($ Million)
Table 57.Turkey Pancreatic Cancer Treatment Market, By Type, 2014-2023 ($Million)
Table 58.Turkey Pancreatic Cancer Treatment Market, By Affected Region, 2014-2023 ($ Million)
Table 59.Saudi Arabia Pancreatic Cancer Treatment Market, By Type, 2014-2023 ($Million)
Table 60.Saudi Arabia Pancreatic Cancer Treatment Market, By Affected Region, 2014-2023 ($ Million)
Table 61.South Africa Pancreatic Cancer Treatment Market, By Type, 2014-2023 ($Million)
Table 62.South Africa Pancreatic Cancer Treatment Market, By Affected Region, 2014-2023 ($ Million)
Table 63.United Arab Emirates Pancreatic Cancer Treatment Market, By Type, 2014-2023 ($Million)
Table 64.United Arab Emirates Pancreatic Cancer Treatment Market, By Affected Region, 2014-2023 ($ Million)
Table 65.Others Pancreatic Cancer Treatment Market, By Type, 2014-2023 ($Million)
Table 66.Others Pancreatic Cancer Treatment Market, By Affected Region, 2014-2023 ($ Million)
Table 67.Roche Holding AG: Key Strategic Developments, 2015-2017
Table 68.Eli Lilly and Company: Key Strategic Developments, 2015-2017
Table 69.Celgene Corporation: Key Strategic Developments, 2015-2017
Table 70.Novartis AG: Key Strategic Developments, 2015-2017
Table 71.Pfizer: Key Strategic Developments, 2015-2017
Table 72.Clovis Oncology: Key Strategic Developments, 2015-2017
Table 73.Amgen: Key Strategic Developments, 2015-2017
Table 74.Teva Pharmaceutical Industries Ltd: Key Strategic Developments, 2015-2017
Table 75.Merck & Co.: Key Strategic Developments, 2015-2017


List of Figures

Figure 1.Global Pancreatic Cancer Treatment Market Share, By Type, 2012 & 2023
Figure 2.Global Pancreatic Cancer Treatment Market, By Affected Region, 2014 & 2023($Million)
Figure 3.Global Pancreatic Cancer Treatment Market, By Region, 2014 & 2023 ($Million)
Figure 4.Roche Holding AG: Net Revenues, 2014-2016 ($Million)
Figure 5.Roche Holding AG: Net Revenue Share, By Segment, 2016
Figure 6.Roche Holding AG: Net Revenue Share, By Geography, 2016
Figure 7.Eli Lilly and Company: Net Revenues, 2014-2016 ($Million)
Figure 8.Eli Lilly and Company: Net Revenue Share, By Segment, 2016
Figure 9.Eli Lilly and Company: Net Revenue Share, By Geography, 2016
Figure 10.Celgene Corporation: Net Revenues, 2014-2016 ($Million)
Figure 11.Celgene Corporation: Net Revenue Share, By Segment, 2016
Figure 12.Celgene Corporation: Net Revenue Share, By Geography, 2016
Figure 13.Novartis AG: Net Revenues, 2014-2016 ($Million)
Figure 14.Novartis AG: Net Revenue Share, By Segment, 2016
Figure 15.Novartis AG: Net Revenue Share, By Geography, 2016
Figure 16.Merck & Co.: Net Revenues, 2014-2016 ($Million)
Figure 17.Merck & Co.: Net Revenue Share, By Segment, 2016
Figure 18.Merck & Co.: Net Revenue Share, By Geography, 2016

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix

Supply Side

Demand Side

Primary Data Sources

  • Manufacturers
  • Distributors & Wholesalers
  • GPOs
  • Physicians/Specialist
  • Healthcare Providers
  • Consumers

Secondary Data Sources

  • Annual Reports/SEC Filings/ Investor Presentations/ Press Releases
  • Government/Associations Publications
  • Case Studies
  • Reference Customers

 

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

  • Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
  • Number of patients for particular device or medical procedure and
  • Repeated use of particular device depending on health and condition of patient
  • Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

Industry Analysis

Qualitative Data

Quantitative Data (2017-2025)

  • Market Dynamics (Drivers, Restraints, and Challenges)
  • Industry Trend Analysis
  • Market Opportunities
  • Government Policies and Regulations, Patent Analysis, and Reimbursement Policies
  • Porter’s Five Forces and PESTLE Analysis
  • Key Developments and Competitive Landscape
  • Market Assessment and Forecast
  • Market Assessment and Forecast, By Product
  • Market Assessment and Forecast, By Technology
  • Market Assessment and Forecast, By Application
  • Market Assessment and Forecast, By End User
  • Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

*
*
*
*
*